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Abstract
Background The aim of this study was to evaluate the effect
of sleeve gastrectomy (SG) and Roux-en-Y-bypass (RYGB)
on anthropometric and biochemical parameters, including
changes in glucose levels, lipid profile and liver function.
Drastic decrease in all lipid fractions a few weeks or months
after the surgery could be regarded as favourable, but low
level of HDL is an independent risk factor for heart diseases.
Extreme load on the liver without preparation of the patient to
the surgery can have negative consequences.
Methods The test group comprised of 40 female patients at
the age of 42.96 with average body weight of 131.56 kg and
BMI 46.49. Biochemical analyses were performed using ca-
lorimetric method.
Results No statistically significant differences were observed
in glucose levels between the two types of procedures. The
highest differences were noted for triglycerides levels, which
decreased, as well as all cholesterol fractions, after RYGB, but
were increasing during the first months after SG procedure.
Changes in lipid profile, caused by the reduction of all lipid
fractions, were more visible after RYGB. The decrease in total
cholesterol directly and activity of liver enzymes after the
procedure was as higher after RYGB as after SG. Increased
activity of transaminases indicates significant liver overload.
Conclusions With the selection of groups of patients with
similar initial parameters, it is not clear whether the
differences between the two procedures when assessing the
improvement of glycaemia are significant. However, due to
invasive character of RYGB, liver overload lasting several
months and lifelong limited absorption of nutrients, the pos-
sibility of SG procedure should be considered as a first option.
Keywords Bariatric surgery . Dyslipidaemia . Fatty liver .
Glucosemetabolism . Obesity therapy
Introduction
Obesity is an epidemic, which is a serious health and socio-
economic problem both on individual and global scales. It
facilitates the development of numerous diet-related diseases
linked to the occurrence of metabolic syndrome. It is a state
when fatty tissue comprises of more than 20 % of total body
weight in men and 25 % in women, but the percentage can be
higher in older people [2]. The basic method to fight obesity is
the introduction of a rational diet, maintain proper dietary
habits and increase physical activity. Body mass reduction
using these methods is a long time process and can be inef-
fective in the case of people with hormonal imbalances or
metabolic disorders, and additionally low level of physical
activity or with genetic load [10, 27]. Bariatric surgery is the
quickest and most effective means of body mass and fatty
tissue reduction [17]. However, body weight loss is most pro-
nounced in the first 3 months after the procedure, and later, the
weight reduction becomes slower. The factors contributing to
the body mass loss during this period are radical reduction of
consumed food, physiologically induced metabolic changes
(bile acids), hormonal changes (fatty tissue, intestines) and
modifications in nerve signalling and in intestinal microflora
[4, 9]. The influence of neurohormones produced in small
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intestine becomes more pronounced, and the decrease in their
levels leads to the reduction of insulin synthesis and insulin
resistance of the tissues [21]. Bariatric treatment, however,
poses several health threats, including those linked to the com-
plications related to the surgery itself, such as mortality during
30 days after the procedure (0.5–1.5 %), internal haemorrhage
requiring reoperation (2 %), risk of occurring abscesses and
leaks or venous thrombosis [1, 7, 16]. Long-term conse-
quences are related to nutritional deficiencies, being the cause
of osteoporosis or anaemia due to iron and cobalamin defi-
ciencies, and require lifelong supplementation [11, 12, 15].
Indications for bariatric surgery in obesity treatment include
high BMI—above 40 kg/cm2—the presence of diet-related
diseases, such as high blood pressure, type 2 diabetes, meta-
bolic syndrome, osteoarthritis, restrictive ventilatory defects
and numerous unsuccessful dietetic interventions. Selection
of appropriate treatment leading to body mass reduction
should be rational and preceded by full information on avail-
able procedures. On the other hand, not considering any other
treatments besides bariatric surgery in preventing the develop-
ment of obesity-related diseases is the worst solution of all.
There are clear indications (especially those related to diabetes
and glycaemic control) supporting the use of RYGB. The
discussion on using RYGB procedure in diabetes treatment
is still on-going [3, 5, 8]. Another positive aspect corresponds
to significant changes in lipid profile—a decrease in concen-
tration of triglycerides and an increase in triglyceride-rich li-
poproteins (TRLs) due to both reduced TRL clearance from
the circulation and increased production by the liver (apoB-
100 containing VLDLs) and intestine (apoB-48 containing
chylomicrons) [8]. It seems though that, besides that improve-
ment, after a year from the surgery, directly after the procedure
and until about half a year after it, there is a deterioration in
some blood biochemical parameters, including HDL, which
results from increased lipolysis and insufficient intake of pro-
tein during postoperative period. Is being discussed better
methods of bariatric surgery in the treatment of not only obe-
sity but also metabolic diseases like diabetes, lipid disorders
and hepatic steatosis. Opinions are strongly divided. The
study compares two methods of SG and RG in these three
aspects at the annual observation of patients with similar base-
line characteristics.
Aim of the Study The objective of the study was to observe
the patients and compare the effectiveness of the improvement
of biochemical parameters in both types of procedures (RYGB
and SG) during 12 months after the procedure. The changes
occur during the first period after the procedure and should be
thoroughly understood and properly interpreted to be able to
precisely adjust dietary recommendations facilitating the re-
covery. There are few studies reporting dietary recommenda-
tions for people after bariatric treatment; however, they do not
consider the need of supplementation of patients’ diets with
monounsaturated fatty acids and lipotropic compounds, which
prevent fatty liver disease [23]. It seems that due to increased
lipolysis, being an outcome of postoperative stress and long-
term fasting, a liver may require such support.
Materials and Methods
To perform the studies, the consent of the Bioethical
Commission at Pomeranian Medical University was obtained
(No KB-0012/34/04/2014).
Criteria regarding the test groupDuring the selection of the
patients, we tried to include the patients (representing those
who may be considered for bariatric surgery by NICE criteria)
for whom such factors as sex, age, body weight and biochem-
ical parameters were corresponding in both groups (RYGB
and SG). The average age of 39 women in the test group
was 43.7 ± 11.18. The average body weight was 131.6 kg
and waist circumference 139.2 cm. All female patients under
study had previous history of numerous unsuccessful attempts
of losing weight using diets. Based on anthropometric mea-
surements—body weight, height, waist and hip circumfer-
ence—an average BMI and WHR indexes were determined
(Table 1). A 31.25 % of women suffered from both diet-
related diseased and hypothyroidism-treated pharmacologi-
cally. In 56.25 % of women, besides obesity, diet-related dis-
eases were present, and other women were qualified for sur-
gery due to numerous attempts to treat obesity using diets with
no successful effects. Women were treated using one of the
bariatric procedures—sleeve gastrectomy (SG) or Roux-en-Y-
bypass (RYGB). The decision on which method was used was
based on the criteria presented in the table below and personal
questionnaire (Table 1).
The selection of patients according to age and results of
anthropometric measurements was deliberate. The aim of this
deliberate selection was to collect the patients who, from the
point of view of the person performing the study, would pro-
vide optimal information for the goal of the study. Therefore,
no statistic differences were observed between the test groups
(Table 2).
Table 1 Criteria for selection of the method of bariatric treatment
Criterion RYGB SG
Age (years) Younger people
<30 years of
age
>30 years of age






theory of diabetes remission)
Dietary habits Bsweet eaters^ People who gorge themselves,
large volume meals
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Biochemical Analyses
Blood from the patients was collected after fasting and lipid
profile, and liver tests and glucose level were measured using
calorimetry (Cobas Integra 400 plus Roche, Switzerland) at
the Department of General and Vascular Surgery.
Statistical Analysis
Statistical analysis was performed using STATISTICA
12.5 (Statsoft, Tulsa, Oklahoma, USA). The arithmetical
mean, standard deviation and the significance of differ-
ences were calculated using ANOVA. Because most of
the distributions differed from the normal distribution
(Shapiro–Wilk test), further analysis involved non-
parametric tests. Dependent samples test was used. The
level of significance was p ≤ 0.05.
Results
Characteristics of the Test Group
The majority of women subjected to bariatric surgery
lived in cities (78.12 %). The 18.75 % of women were
highly educated, 56.25 % completed secondary education
and 25 % obtained primary or vocational education.
Among employed women, the dominating nature of work
was physical (43.75 %) or mixed physical and intellectual
(43.75 %). As much as 78.12 % of questioned women
declared spending their free time in a passive way. Fifty
per cent of patients ate between meals, mostly in stressful
situations and to relax, and every tenth person snacked at
night. In the test group, large differences were observed in
the incidence rate of postoperative complications
(vomiting, constipation, diarrhoea)—in the group after
RYGB, the complications occurred in 37.5 % of patients,
whereas in the group after SG, in 78.12 % of patients.
Changes in Anthropometric Parameters
When comparing the reduction of anthropometric parameters
after two bariatric procedures (RYGB and SG), the lack of
significant differences was observed in body mass reduction,
waist and hip circumference, and BMI and WHR (Table 3).
Changes in Biochemical Parameters after RYGB
Changes in particular parameters in patients’ blood were dif-
ferent depending on the type of surgery. Before the procedure,
the average concentration of cholesterol and its fractions in
RYGB group amounted to total cholesterol of 200 mg/dl
(SD 31.5), including TG of 148.06 mg/dl (SD 112.3), HDL
of 52.36 mg/dl (SD 14.11) and LDL of 123.81 mg/dl (SD
30.3), as in Fig. 1a–d. The average level of aminotransferases
was in the case of ALT 37.33 U/I (SD 21.3) and AST 26.7 U/I
(SD 11.6), and the level of glucose was 108.3 mg/dl (SD
32.91).
Table 2 Characteristics of the
test group of women before the
surgery
Parameter Total (SG + RYGB) RYGB SG
Age (years) 42.96 ± 10.45 42.97 ± 10.10 42.95 ± 10.53
Body weight (kg) 131.56 ± 14.18 130.08 ± 14.41 132.32 ± 13.88
Height (cm) 168.37 ± 8.69 168.49 ± 8.71 168.12 ± 8.75
WC (cm) 139.2 ± 14.33 138.38 ± 13.97 140.15 ± 14.98
HC (cm) 143.50 ± 13.73 142.77 ± 14.01 144.23 ± 12.87
BMI (kg/m2) 46.49 ± 6.78 45.82 ± 6.66 46.81 ± 7.06
WHR 1.02 ± 0.11 1.02 ± 0.10 1.02 ± 0.11
No statistically significant differences (p > 0.05)
Table 3 Comparison of the
effects of anthropometric
parameters reduction 1 year after
the surgery
Tested parameter 12 months after RYGB 12 months after SG p value Statistical significance*
Body weight (kg) 95.79 ± 15.1 94.27 ± 12.3 0.283 NS
WC (cm) 104.91 ± 16.25 103.96 ± 16.42 0.535 NS
HC (cm) 119.64 ± 14.32 119.36 ± 14.2 0.586 NS
BMI (kg/m2) 33.96 ± 4.97 33.69 ± 4.16 0.523 NS
WHR 0.876 ± 0.072 0.846 ± 0.071 0.055 NS
Reduction (kg) 32.27 ± 13.9 31.02 ± 12.3 0.138 NS
*No statistically significant differences were observed between two procedures
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During a month after RYGB, a significant decrease was
observed in the level of total cholesterol on average by
54.2 mg/dl, triglycerides by 54.22 mg/dl, HDL by 10.9 mg/
dl and LDL by 33.73 mg/dl. These were statistically signifi-
cant changes, but in the subsequent months, the levels of par-
ticular fractions fluctuated differently. The concentration of
TG decreased with every measurement made every 3 months,
reaching final value of 59.54 mg/dl, and similar observations
were made for LDL. The level of HDL, after a period of
critical reduction to 41.41 mg/dl (SD 14.02), was increasing
in subsequent periods to the value of 65.73 mg/dl (SD 21.7)
1 year after the procedure. The levels of liver enzymes in-
creased significantly 1 month after the surgery in the case of
ALT and AST, and reached the levels 57.95 (SD 24.14) and
38.95 (SD 19.2), respectively. The activity of both enzymes
until the 6th month after the procedure was decreasing statis-
tically significantly, but from 6th to 12th month after the sur-
gery, the values were stable at the level of reference values and
reached 20.62 U/I (SD 15.0) for ALT and 18.67 U/I (SD 9.0)
for AST (Fig. 2a, b). The level of glucose in RYGB patients
was decreasing almost linearly reaching the value of
83.62 mg/dl (Fig. 3).
Changes in Biochemical Parameters After SG
In SG group before the procedure, the average levels of total
cholesterol and its fractions HDL, LDL and triglycerides
amounted to, respectively, 215.03 mg/dl (SD 33.72),
60.08 mg/dl (SD 10.95), 134,34 mg/dl (SD 26.58) and
100.3 mg/dl (SD 58.14) . The concentra t ions of
aminotransferases were 34.22 mg/dl (SD 18.99) for ALT and
30.33 mg/dl (SD 17.98) for AST, and glucose level was
113.55 mg/dl (34.15).
During a month after SG procedure, a significant decrease
was observed in the levels of total cholesterol by, on average,
20.31 mg/dl, HDL by 10.9 mg/dl, and LDL by 33.73 mg/dl.
On the other hand, the level of triglycerides increased by
17.78 mg/dl. These changes were statistically significant. In
subsequent months, the concentration of TG was decreasing,
reaching the final value of 84.32 mg/dl. Similar observations
were made for LDL—its final concentration reached
112.29 mg/dl. The concentration of HDL, after the period of
greatest drop to 49.82 mg/dl (SD 14.02), constantly increased
in further months reaching the level of 65.73 mg/dl (SD 21.7)
1 year after the surgery (Fig. 1a–d). The levels of liver en-
zymes were stabilized at the initial level up to 1 month after
the procedure, whereas the activity of AST was decreasing.
The highest changes in activity (reduction) of AST were ob-
served in first month after the surgery and, in the case of ALT,
up to 3 months after the procedure (Fig. 2a, b). Glucose level
in patients in SG group, similarly as in RYGB group, de-
creased linearly, reaching the level of 88.12 mg/dl (Fig. 3).
Statistically significant relations related to Figs. 1–3 are pre-
sented in Table 4—for parameters measured for RYGB and
SG.
Comparison of Biochemical Parameters Between RYGB
and SG 1 Year After the Surgery
Twelve months after the surgery, the reduction in transami-
nases activity was on comparable level in both groups. The
level of total cholesterol and its fractions—LDL and triglyc-
erides—significantly decreased in RYGB group, as compared
to SG group, and HDL was on similar level in both groups
(p = 0.112). Also, glucose concentration was not statistically
significantly different between the two groups (Table 5).
Discussion
Sleeve gastrectomy (SG) is based on the surgical removal of
ca. 70–80 % of the stomach along the greater curvature. The
effect of the procedure consists in the reduction of the volume
of consumed food and hunger due to decreased secretion of
ghrelin and reduced nerve signalling [13]. In the method
called Roux-en-Y-bypass (RYGB), the stomach is divided be-
low the lower stomach outlet horizontally into two parts. The
upper part forms smaller stomach pouch connected to small
intestine loop via a BRoux limb^. Lower part remains physi-
ologically linked to duodenum and proximal part of jejunum,
through which the bile and digestive enzymes are transported.
Digestion and absorption are thus limited, because they occur
on a shorter distance of the gastrointestinal tract. The
Fig. 1 Changes in concentration of lipid fractions after bariatric surgeries
performed using two methods
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disadvantages of the first method are twice as frequent post-
operative problems such as vomiting, constipation or diar-
rhoea. The disadvantages of the second method are the neces-
sity of lifelong supplementation in vitamins and minerals and
regular control of their level in the organism, as well as higher
invasiveness of the surgery and, due to that, more frequent
postoperative complications leading to death [7].
Interestingly, in the study of Stumpf et al., the worst impact
on the tolerance of food after the procedure was observed for
the least invasive method, i.e. gastric banding (out of three
examined methods: gastric banding, SG and RYGB) [24].
One of the advantages of RYGB seems to be the improvement
in glycaemia [5, 18]. However, in our study, with the selection
of patients with similar initial parameters, the improvement in
glycaemia after RYGB was not statistically significant with
respect to SG. Both in our study and in the studies of other
authors, the reduction in body weight measured shortly after
the surgery and after longer period of time (ca. 1 year) is
comparable [17]. In both bariatric procedures, a metabolic
response to trauma leads to the development of signalling
via neurohormonal way. Its aim is to turn on own energy
reserves and supply energetic and building substrates to
wound healing process [22]. Undergoing metabolic changes
very quickly leads to catabolism, which has the following
biological effect: lower retention of sodium ion and water in
the organism, increased glucose concentration in blood
(caused by glycolysis, gluconeogenesis and glycogenolysis)
and reduction of pain. Catabolic effects also involve escalated
degradation of protein, increased concentration of ketone bod-
ies, loss of nitrogen with urine and negative nitrogen balance,
which modulates immune system in a response to inflamma-
tory stimuli. In the first postoperative period, the energy de-
mand is increasing, body temperature is growing, hyperventi-
lation occurs and the energy is crucial to sustain proper tissue
perfusion, ATP and phosphocreatine levels, and thus proper
wound healing. The study of Tam et al. shows, however, that
the resting energy expenditure (REE) adaptation mechanism
after both types of surgeries (SG and RYGB) does not con-
tribute to body mass reduction, because REE lowers by 130–
300 kcal/day and these are long-term changes—measurable
even 2 years after the surgery [25].
The concentrations of all lipid fractions of the serum de-
creased. Lipids are transported by apolipoproteins, and when
the system becomes defective, the concentration of lipids in
serum increases. In our case, we have an opposite situation,
which is probably caused by two unrelated mechanisms. First
Fig. 2 Changes in transaminases concentrations after bariatric surgeries performed using two methods
Fig. 3 Changes in glucose concentration after bariatric surgeries
performed using two methods
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of them, confirmed in the literature, relates to the decrease in
insulin concentration and better glycaemic control [9, 18].
Lower insulin levels lead to increased secretion of fatty acids
from fatty tissue. In principle, insulin inhibits lipase in fatty
tissue; therefore, lower concentration of insulin facilitates the
release of fatty acids and glycerol [20]. Therefore, we should
observe the increased concentration of fatty acids in blood
serum. It was also shown that reduction in insulin level is
accompanied by the decrease in the activity of pyruvate dehy-
drogenase, acetyl-CoA carboxylase and glycerol-3-phosphate
acyltransferase. Lower activity of these enzymes results in
reduced synthesis of cholesterol and, consequently, steroid
hormones.
During postoperative period, besides the mechanisms
outlined above, there is also long-lasting fasting period
resulting from restrictive dietary requirements [14]. Low in-
take of food leads to a distortion of signals from the intestines
stimulating transporters synthesis. During fasting, a much
larger amount of fat is burned than it would appear based on
the amount of oxidized free fatty acids. It seems that such a
large reduction in all serum lipid fractions during the 3 months
after the surgery is caused by similarly low concentration of
apolipoproteins transporting cholesterol esters. The synthesis
of apolipoproteins and phospholipids is blocked. Reduced syn-
thesis of phospholipids is caused by the lack of choline, which
is not present in bariatric patient’s diet due to the elimination or
drastic limitation of the consumption of meat, especially liver,
eggs and wholegrain products. It can be expected that endoge-
nous production of choline by intestinal bacterial flora is also
stopped due to changes inmicrobiota [9, 26]. Additionally, lipid
synthesis is affected by the deficiency in essential fatty acids,
which also influences the reduction of HDL, so their supple-
mentation in a diet should be considered. During fasting, ketone
bodies become the major source of energy instead of glucose,
which leads to the reduction in glucose demand. Nevertheless,
small amounts of glucose are necessary and are synthesized
Table 4 A p value for biochemical parameters after RYGB and SG considering period of time
p value for biochemical parameters after RYGB
Parameter Before:1 Before:3 Before:6 Before:12 1:3 1:6 1:12 3:6 3:12 6:12
ALT 0.294 0.035* 0.008* 0.005* 0.012* 0.000* 0.000* 0.000* 0.000* 0.939
AST 0.081 0.099 0.080 0.080 0.350 0.350 0.167 0.020* 0.720 0.923
TC 0.000* 0.000* 0.028* 0.055 0.907 0.927 0.596 0.977 0.389 0.315
HDL 0.000* 0.033* 0.592 0.012* 0.022* 0.000* 0.000* 0.008* 0.000* 0.001*
LDL 0.163 0.014* 0.006* 0.000* 0.984 0.321 0.073 0.098 0.000* 0.352
TG 0.685 0.151 0.035* 0.061 0.002* 0.000* 0.000* 0.056 0.070 0.570
Glucose 0.129 0.910 0.027* 0.021* 0.210 0.007* 0.011* 0.042* 0.027* 0.140
p value for biochemical parameters after SG
Parameter Before:1 Before:3 Before:6 Before:12 1:3 1:6 1:12 3:6 3:12 6:12
ALT 0.295 0.035* 0.008* 0.005* 0.012* 0.000* 0.000* 0.000* 0.000* 0.939
AST 0.081 0.099 0.080 0.080 0.354 0.455 0.167 0.019* 0.072 0.923
TC 0.000* 0.000* 0.028* 0.055 0.901 0.927 0.595 0.977 0.389 0.316
HDL 0.000* 0.033* 0.592 0.012* 0.023* 0.000* 0.000* 0.008* 0.000* 0.001*
LDL 0.163 0.014* 0.006* 0.000* 0.984 0.321 0.073 0.098 0.000* 0.352
TG 0.683 0.151 0.035* 0.060 0.002* 0.000* 0.000* 0.057 0.070 0.570
Glucose 0.050* 0.020* 0.003* 0.004* 0.040* 0.000* 0.000* 0.011* 0.005* 0.766
*Statistically significant differences (p > 0.05)
Table 5 Comparison of
biochemical parameters of female
patients after both bariatric
procedures (RYGB and SG)
12 months after the surgery
Tested parameter 12 months after RYGB 12 months after SG p value Statistical significance
ALT (U/I) 20.62 ± 15.01 20.00 ± 12.96 0.891 NS
AST (U/I) 18.67 ± 9.01 18.89 ± 5.64 0.928 NS
TC (mg/dl) 158.08 ± 45.00 200.51 ± 26.84 0.001 S
TG (mg/dl) 59.54 ± 24.24 84.32 ± 26.38 0.004 S
HDL (mg/dl) 65.73 ± 21.74 77.48 ± 25.04 0.112 NS
LDL (mg/dl) 82.11 ± 30.32 112.29 ± 27.34 0.023 S
Glucose (mg/dl) 83.62 ± 20.71 88.12 ± 4.01 0.419 NS
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from amino acids, coming from degraded muscle proteins and
from small amounts consumed with food. It seems that surgery
using SG procedure, due to its character, can cause more severe
proteinmalabsorption in the stomach. If lower differences in the
reduction of particular lipid fractions were shown for the pa-
tients after RYGB, it could prove this thesis. However, we were
unable to observe such relation in our study.
Referring to our hypothesis related to fatty liver after bar-
iatric surgery, we can definitely observe that liver becomes
overloaded, because even though the concentration of alanine
aminotransferase (ALT) and aspartate aminotransferase (ASP)
did not increase statistically significantly, they increased con-
siderably—by more than 10 %. Therefore, it would be advis-
able to supplement the diet with pyridoxal phosphate, a cofac-
tor of transaminases, and orotic acid, which lowers the con-
centration of lipoproteins containing apo B. Various reports in
the literature concerning lipid profile in bariatric patients indi-
cate that the stabilization of lipid profile occurs after 12months
[6]. There are also reports showing on its significant improve-
ment 2 years after the surgery in 92.3 % of patients and un-
changed level of HDL [19]. Corwell et al. also observed that
3 months after the procedure, the level of triglycerides had
decreased, but in contradiction to other studies, they claimed
that HDLwas increasing starting from 1 year after the surgery.
Bariatric surgeries using gastric bypass (RYGB) and sleeve
gastrectomy (SG) improved the tolerance of glucose in female
patients after fasting. Improvement of glucose tolerance after
bariatric treatment suggests that these effects may contribute to
the decrease of cardiovascular mortality after surgery. With the
selection of groups of patients with similar initial parameters,
the significance of differences between the two procedures
when assessing the improvement of glycaemia is not clear.
The improvement in lipid profile, manifested in reduced
concentration of LDL, triglycerides and total cholesterol, vis-
ible after both surgeries, and very low concentration of HDL
fraction 3 months after the procedures, clearly shows on liver
overload. When preparing the patient to the surgery, it seems
crucial to introduce the diet supplying lipotropic compounds,
complete protein andmonounsaturated fatty acids. To increase
the level of HDL before the surgery and to lower the risk of its
dangerous reduction, the patients should consider daily phys-
ical activity few weeks before the surgery.
It may seem that the recommended bariatric surgery (due to
better effects on lowering cholesterol fractions and less fre-
quent complications) would be RYGB. However, due to its
invasive character, liver overload lasting several months and
lifelong limited absorption of nutrients, the possibility of SG
procedure should be considered as a first option.
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